Cohort profile: The national prostate cancer register of sweden and prostate cancer data base Sweden 2.0

International Journal of Epidemiology

Volumn 42, Issue 4, 2013, Pages 956-967

  Van Hemelrijck, Mieke ^a   Wigertz, Annette ^b   Sandin, Fredrik ^b   Garmo, Hans ^a,b   Hellström, Karin ^b   Fransson, Per ^c   Widmark, Anders ^c   Lambe, Mats ^b,d   Adolfsson, Jan ^d   Varenhorst, Eberhard ^e   Johansson, Jan Erik ^f   Stattin, Pär ^c,g  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^f ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN; CANCER; DATABASE; DISEASE INCIDENCE; EPIDEMIOLOGY; ETIOLOGY; MENS HEALTH; SERUM; TUMOR;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CASE CONTROL STUDY; CAUSE OF DEATH; CLINICAL RESEARCH; COHORT ANALYSIS; CONSERVATIVE TREATMENT; DATA BASE; ERECTILE DYSFUNCTION; FOLLOW UP; GLEASON SCORE; HEALTH CARE; HUMAN; MALE; METASTASIS; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY CONTROL; QUESTIONNAIRE; SWEDEN; URINE INCONTINENCE; WATCHFUL WAITING;

SWEDEN;

ADENOCARCINOMA; ADULT; AGED; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; SWEDEN; URINARY INCONTINENCE;

EID: 84884732244     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dys068     Document Type: Article

References (59)

1. Adolfsson J, Garmo H, Varenhorst E et al. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol 2007;41:456-77.
2. Stattin P, Holmberg E, Bratt O, Adolfsson J, Johansson JE, Hugosson J. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. J Urol 2008;180:2423-29. discussion 9-30.
3. The National Board of Health and Welfare. National Cancer Register. 2011. http://www.socialstyrelsen.se/register/halsodataregister/cancerregistret (1 November 2011, date last accessed).
4. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27-33.
5. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659-67.
6. INCA Sweden. Information network for cancer care 2010. http://www.vinkcancer.se/INCA/kvalitetsregister/ (1 November 2011, date last accessed).
7. Sandblom G, Dufmats M, Olsson M, Varenhorst E. Validity of a population-based cancer register in Sweden - an assessment of data reproducibility in the South-East Region Prostate Cancer Register. Scand J Urol Nephrol 2003;37:112-19.
8. Egevad L. Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images. Urology 2001;57:291-95.
9. Mohler J, Bahnson RR, Boston B, et al. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2010;8:162-200.
10. Fransson P, Tavelin B, Widmark A. Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects. Support Care Cancer 2001;9:187-98.
11. Vickers AJ, Cronin AM, Bjork T, et al. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. BMJ 2010;341: c4521.
12. Manjer J, Carlsson S, Elmstahl S, et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 2001;10:489-99.
13. Stocks T, Lukanova A, Rinaldi S, et al. Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer 2007;120:2678-86.
14. Johansson M, McKay JD, Wiklund F, et al. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18:1644-50.
15. Lindstrom S, Adami HO, Balter K, et al. Genetic variation in the upstream region of ERG and prostate cancer. Cancer Causes Control 2009;20:1173-80.
16. Hagel E, Garmo H, Bill-Axelson A, et al. PCBaSe Sweden: a register-based resource for prostate cancer research. Scand J Urol Nephrol 2009;43:342-49.
17. Statistics in the Areas of Health and Medical Care [database on the Internet] 2007. http://www.socialstyrelsen.se/statistics (1 November 2011, date last accessed).
18. Hammar N, Alfredsson L, Rosen M, Spetz CL, Kahan T, Ysberg AS. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001;30(Suppl. 1):S30-34.
19. Ingelsson E, Arnlov J, Sundstrom J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 2005;7:787-91.
20. Lindblad U, Rastam L, Ranstam J, Peterson M. Validity of register data on acute myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med 1993;21:3-9.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
22. Kastner C, Armitage J, Kimble A, Rawal J, Carter PG, Venn S. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting. Prostate Cancer Prostatic Dis 2006;9:270-74.
23. Berglund A, Garmo H, Tishelman C, Holmberg L, Stattin P, Lambe M. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol 2011;185:833-39.
24. Mucci L, Signorello L, Adami H. Prostate cancer. In: Adami H, Hunter D, Trichopoulos D (eds). Textbook of Cancer Epidemiology. New York: Oxford, 2008, pp. 517-54.
25. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23: 305-13.
26. The Swedish Cancer Registry [database on the Internet] 2008. http://www.socialstyrelsen.se/en/Statistics/statsbysubject/Cancer{thron}Registry.htm (1 November 2011, date last accessed).
27. Fall K, Stromberg F, Rosell J, Andren O, Varenhorst E. Reliability of death certificates in prostate cancer patients. Scand J Urol Nephrol 2008;42:352-57.
28. Godtman R, Holmberg E, Stranne J, Hugosson J. High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm. Scand J Urol Nephrol 2011;45:226-32.
29. Statistics Sweden. Population and Housing Census. 2009. http://www.scb.se/Pages/List____257507.aspx (in Swedish) (1 November 2011, date last accessed).
30. Lagerlund M, Bellocco R, Karlsson P, Tejler G, Lambe M. Socio-economic factors and breast cancer survival - a population-based cohort study (Sweden). Cancer Causes Control 2005;16:419-30.
31. Swedish Socioeconomic Classification. Reports on Statistical Coordination. Sweden: Orebro, 1982.
32. Eloranta S, Lambert PC, Cavalli-Bjorkman N, Andersson TM, Glimelius B, Dickman PW. Does socioeconomic status influence the prospect of cure from colon cancer - a population-based study in Sweden 1965-2000. Eur J Cancer 2010;46:2965-72.
33. Kristinsson SY, Derolf AR, Edgren G, Dickman PW, Bjorkholm M. Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in Sweden. J Clin Oncol 2009;27:2073-80.
34. Statistics Sweden. Sweden: Stockholm, 2008. http://www .scb.se/(1 November 2011, date last accessed).
35. Statistics Sweden. Longitudinal integration database for health insurance and labour market studies (LISA by Swedish acronym) 2008 [cited 7 July 2011]. http://www .scb.se/Pages/List_257743.aspx (1 November 2011, date last accessed).
36. The National Board of Health and Welfare. Swedish Prescribed Drug Register 2010. http://www.socialstyrelsen.se/register/halsodataregister/lakemedelsregistret (1 November 2011, date last accessed).
37. Ekbom A. The Swedish Multi-generation Register. Methods Mol Biol 2011;675:215-20.
38. Bratt O, Garmo H, Adolfsson J, et al. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates. J Natl Cancer Inst 2010;102:1336-43.
39. Nilsson E, Haapaniemi S. The Swedish hernia register: an eight year experience. Hernia 2000;4:286-89.
40. Gudbjornsdottir S, Cederholm J, Nilsson PM, Eliasson B. The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 2003;26:1270-76.
41. RIKS-HIA International. The Register of Information and Knowledge about Swedish Heart Intensive care Admissions 2008 [cited 7 July 2011]. http://www.ucr.uu. se/rikshia/(1 November 2011, date last accessed).
42. Stattin P, Holmberg E, Johansson J, Holmberg L, Adolfsson J, Hugosson J. Outcomes for men with localized prostate cancer in the National Prostate Cancer Register (NPCR) of Sweden. J Natl Cancer Inst 2010;102:950-58.
43. Varenhorst E, Garmo H, Holmberg L, et al. The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival. Scand J Urol Nephrol 2005;39:117-23.
44. Carlsson S, Adolfsson J, Bratt O, et al. Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden. Scand J Urol Nephrol 2009;43: 350-56.
45. Sandblom G, Ladjevardi S, Garmo H, Varenhorst E. The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate. Cancer 2008;112:813-19.
46. Akre O, Garmo H, Adolfsson J, Lambe M, Bratt O, Stattin P. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden. Eur Urol 2011;60:554-63.
47. Regional Oncologic Centre Uppsala. Annual Report of the National Prostate Cancer Register 2011 [cited 26 October 2011]. http://www.roc.se/prostata.asp (1 November 2011, date last accessed).
48. Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol 2000;29:495-502.
49. Mollazadegan K, Kugelberg M, Lindblad BE, Ludvigsson JF. Increased risk of cataract among 28 000 patients with celiac disease. Am J Epidemiol 2011;174:195-202.
50. Thorstenson A, Bratt O, Akre O, et al. Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden. Eur J Cancer 2012;48:1672-81.
51. Van Hemelrijck M, Garmo H, Holmberg L, Stattin P, Adolfsson J. Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden. Eur Urol 2012;61:690-700.
52. Bill-Axelson A, Garmo H, Nyberg U, et al. Psychiatric treatment in men with prostate cancer-results from a nation-wide, population-based cohort study from PCBaSe Sweden. Eur J Cancer 2011;47:2195-2201.
53. Robinson D, Garmo H, Lindahl B, et al. Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden. Int J Cancer 2012; 130:478-87.
54. Akre O, Garmo H, Adolfsson J, Lambe M, Bratt O, Stattin P. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden. Eur Urol 2011;60:554-63.
55. Berglund A, Garmo H, Tishelman C, Holmberg L, Stattin P, Lambe M. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol 2011;185:833-40.
56. Bill-Axelson A, Garmo H, Lambe M, Bratt O, Adolfsson J, Nyberg U, et al. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden. Eur Urol 2010;57:390-95.
57. Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst 2010;102:950-58.
58. Van Hemelrijck M, Garmo H, Holmberg L, et al. Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the population-based PCBaSe Sweden. J Clin Oncol 2010;28:3448-56.
59. Van Hemelrijck M, Adolfsson J, Garmo H, et al. Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol 2010;11:450-58.